Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
08/02/2023 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 581 | $2.94 | $1.7k | | 08/02/2023 |
06/14/2023 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 1.2k | $3.39 | $4.1k | | 06/14/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 135k | $2.77 | $374k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Disposition | Stock Option (Right to Buy) | 25k | $29.40 | $735k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 25k | $2.77 | $69.2k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Disposition | Stock Option (Right to Buy) | 15k | $59.75 | $896.2k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 15k | $2.77 | $41.6k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Disposition | Stock Option (Right to Buy) | 29k | $41.80 | $1.2M | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 29k | $2.77 | $80.3k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Disposition | Stock Option (Right to Buy) | 56.7k | $10.60 | $600.7k | | 05/11/2023 |
05/11/2023 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 56.7k | $2.77 | $157k | | 05/11/2023 |
05/11/2023 | Nguyen Alexander Hieu | See Remarks | Grant | Stock Option (Right to Buy) | 40k | $2.77 | $110.8k | | 05/11/2023 |
05/11/2023 | Nguyen Alexander Hieu | See Remarks | Disposition | Stock Option (Right to Buy) | 2.1k | $41.80 | $87.1k | | 05/11/2023 |
05/11/2023 | Nguyen Alexander Hieu | See Remarks | Grant | Stock Option (Right to Buy) | 2.1k | $2.77 | $5.8k | | 05/11/2023 |
05/11/2023 | Nguyen Alexander Hieu | See Remarks | Disposition | Stock Option (Right to Buy) | 18.3k | $10.60 | $194.3k | | 05/11/2023 |
05/11/2023 | Nguyen Alexander Hieu | See Remarks | Grant | Stock Option (Right to Buy) | 18.3k | $2.77 | $50.8k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Grant | Stock Option (Right to Buy) | 40k | $2.77 | $110.8k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Disposition | Stock Option (Right to Buy) | 24k | $99.60 | $2.4M | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Grant | Stock Option (Right to Buy) | 24k | $2.77 | $66.5k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Disposition | Stock Option (Right to Buy) | 12.3k | $41.80 | $515.5k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Grant | Stock Option (Right to Buy) | 12.3k | $2.77 | $34.2k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Disposition | Stock Option (Right to Buy) | 20k | $10.60 | $212k | | 05/11/2023 |
05/11/2023 | Sullivan Lynne Marie | See Remarks | Grant | Stock Option (Right to Buy) | 20k | $2.77 | $55.4k | | 05/11/2023 |
05/01/2023 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 1k | $2.15 | $2.2k | | 05/01/2023 |
03/31/2023 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 2k | $1.70 | $3.3k | | 03/31/2023 |
03/31/2023 | Dananberg Jamie | Chief Medical Officer | Sale | Common Stock, $0.0001 par value | 420 | $1.70 | $714 | | 03/31/2023 |
03/14/2023 | Dananberg Jamie | Chief Medical Officer | Sale | Common Stock, $0.0001 par value | 1k | $4.00 | $4k | | 03/14/2023 |
03/14/2023 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 1.2k | $4.00 | $4.8k | | 03/14/2023 |
12/14/2022 | Ghosh Anirvan | CEO | Sale | Common Stock, $0.0001 par value | 1.3k | $2.85 | $3.6k | | 12/14/2022 |
12/14/2022 | Dananberg Jamie | Chief Medical Officer | Sale | Common Stock, $0.0001 par value | 1k | $2.85 | $2.9k | | 12/14/2022 |
11/18/2022 | Ghosh Anirvan | CEO | Grant | Stock Option (Right to Buy) | 200k | $2.38 | $476k | | 11/18/2022 |
11/18/2022 | Nguyen Alexander Hieu | See Remarks | Grant | Stock Option (Right to Buy) | 65k | $2.38 | $154.7k | | 11/18/2022 |
11/18/2022 | Dananberg Jamie | Chief Medical Officer | Grant | Stock Option (Right to Buy) | 65k | $2.38 | $154.7k | | 11/18/2022 |
11/18/2022 | Sullivan Lynne Marie | See Remarks | Grant | Stock Option (Right to Buy) | 80k | $2.38 | $190.4k | | 11/18/2022 |
09/14/2022 | Dananberg Jamie | Chief Medical Officer | Sale | Common Stock, $0.0001 par value | 10.9k | $0.48 | $5.2k | | 09/14/2022 |
|